Cerebras Systems Inc.
NASDAQ:CBRSSemiconductors
+$19.07 today
- Market cap
- $21.33B
- Beta
- 0.00
- P/E (TTM)
- 210.7
- EPS (TTM)
- $1.10
Volume 12.77M
Average 8.03M
CBRS Interest Expense
Cost of servicing the company's debt during the period.
Cerebras Systems Inc.NASDAQ: CBRS
Interest Expense · Q3 FY2026 · quarter ended Sep 2026
Interest expense remains negative
Q3 FY2026 interest expense was $18.57M, compared with $0 a year earlier. Trailing-twelve-month interest expense was $37.52M.
Context
- Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Interest expense increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly interest expense holds near $18.57M or moves back toward the trailing-twelve-month quarterly average of $9.38M.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Interest Expense vs competitors
How CBRS compares with its peers on the latest reported figures
- CBRS's LTM Sep 2026 interest expense of $37.52M is the 5th highest of the 7 companies compared; the peer median is $170.79M.
- Interest expense amounts to 5.0% of revenue for CBRS, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.41B | +143.3% | +406.8% | 24.4% | |
| LTM Jul 2026 | $463M | +87.4% | -0.4% | 0.2% | |
| LTM Jun 2026 | $194.57M | +226.6% | +164.7% | 0.5% | |
| LTM Jun 2026 | $147M | +47.0% | +14.2% | 0.4% | |
| LTM Sep 2026 | $37.52M | — | — | 5.0% | |
PENGPenguin Solutions, Inc. | LTM Aug 2026 | $1.42M | -80.6% | -77.1% | 0.1% |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding CBRS) | $170.79M | +67.2% | +14.2% | 0.3% | |
Competitors are the stored peer set for CBRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 24.62M | 78.74M | 290.25M | 509.99M |
| Cost of Revenue | 21.73M | 52.39M | 167.51M | 310.92M |
| Gross Profit | 2.89M | 26.36M | 122.74M | 199.07M |
| Gross Margin | 11.7% | 33.5% | 42.3% | 39.0% |
| Research & Development | 155.41M | 140.06M | 158.23M | 243.32M |
| Selling, General & Admin | 26.3M | 20.24M | 65.94M | 101.61M |
| Operating Expenses | 181.71M | 160.29M | 224.38M | 344.33M |
| Depreciation & Amortization | 11.94M | 10.58M | 11.54M | 34.45M |
| EBITDA | (165.57M) | (116.44M) | (468.14M) | 279.34M |
| EBITDA Margin | -672.5% | -147.9% | -161.3% | 54.8% |
| Operating Income | (178.82M) | (133.93M) | (101.64M) | (145.25M) |
| Operating Margin | -726.4% | -170.1% | -35.0% | -28.5% |
| Interest Income | 1.08M | 5.68M | 23.23M | 26.8M |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 1.31M | 6.91M | (378.04M) | 390.14M |
| Income Before Tax | (177.52M) | (127.02M) | (479.68M) | 244.88M |
| Pre-Tax Margin | -721.0% | -161.3% | -165.3% | 48.0% |
| Income Tax Expense | 204K | 132K | 1.93M | 7.06M |
| Net Income | (177.72M) | (127.16M) | (481.6M) | 237.83M |
| Net Margin | -721.9% | -161.5% | -165.9% | 46.6% |
| EPS (Basic) | (0.83) | (0.59) | (2.25) | 0.41 |
| EPS (Diluted) | (0.83) | (0.59) | (2.25) | 0.41 |
| Weighted Avg Shares | 215.23M | 215.23M | 215.23M | 215.23M |
| Weighted Avg Shares (Diluted) | 215.23M | 215.23M | 215.23M | 215.23M |
Cerebras Systems Inc.
NASDAQ:CBRS
Intrinsic Alpha fair value
Locked
Current Price
$94.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.